Congratulations! [Software]

posted by Helmut Homepage – Vienna, Austria, 2019-12-01 13:50  – Posting: # 20903
Views: 223

Hi PharmCat,

my deepest respect for the work you have done! Julia is a nasty beast (IMHO, more than SAS and R combined). :-D

» […] Covariance structure: CSH (Type C).

OK, the FDA’s guidance states:

    PROC MIXED;
    CLASSES SEQ SUBJ PER TRT;
    MODEL Y = SEQ PER TRT/ DDFM=SATTERTH;
    RANDOM TRT/TYPE=FA0(2) SUB=SUBJ G;
    REPEATED/GRP=TRT SUB=SUBJ;
    ESTIMATE 'T vs. R' TRT 1 -1/CL ALPHA=0.1;

In the Random statement, TYPE=FA0(2) could possibly be replaced by TYPE=CSH.


(my emphasis)

In some of our reference datasets (and terrible ones posted by John in the forum) of the partial replicate TRR|RTR|RRT we ran into convergence issues with FA0(2) but never with FA0(1) and CSH. Do I understand correctly that you have given up to support partial replicates as all?

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
20,130 posts in 4,245 threads, 1,384 registered users;
online 28 (1 registered, 27 guests [including 16 identified bots]).
Forum time (Europe/Vienna): 12:04 CET

Be very, very careful what you put into that head,
because you will never, ever get it out.    Thomas Wolsey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5